Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program-Reference-Cited by-同舟云学术

Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program

Published:2020-05-04 Issue:6 Volume:60 Page:1243-1252
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Bloch Evan M.¹^ORCID,Kipiani Eteri²,Shadaker Shaun³,Alkhazashvili Maia²^ORCID,Gvinjilia Lia⁴,Kuchuloria Tinatin⁴,Chitadze Nazibrola²,Keating Sheila M.⁵⁶^ORCID,Gamkrelidze Amiran²,Turdziladze Alexander²,Getia Vladimer²,Nasrullah Muazzam³,Averhoff Francisco³,Izoria Mariam²,Skaggs Beth⁴

Affiliation:

1. Johns Hopkins School of Medicine Baltimore Maryland USA

2. National Center for Disease Control and Public Health Tbilisi Georgia

3. Division of Viral Hepatitis National Center for HIV, Hepatitis, STD&TB PreventionCenters for Disease Control and Prevention Atlanta Georgia USA

4. South Caucasus Office of the U.S. Centers for Disease Control (CDC) Tbilisi Georgia

5. Vitalant Research Institute (formerly Blood Systems Research Institute) San Francisco California USA

6. University of California San Francisco San Francisco California USA

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15815

Reference37 articles.

1. WHO. Hepatitis C: key facts [monograph on the Internet]. 2018. Available from:https://www.who.int/news-room/fact-sheets/detail/hepatitis-c

2. Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C

3. Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

4. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

5. Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Banking Capacity in Low-and Middle-Income Countries: Covid-19 Convalescent Plasma in Context;Current Topics in Microbiology and Immunology;2024

2. Advancing blood transfusion safety using molecular detection in the country of Georgia;Transfusion Clinique et Biologique;2023-08

3. Toward reaching hepatitis B goals: hepatitis B epidemiology and the impact of two decades of vaccination, Georgia, 2021;Eurosurveillance;2023-07-27

4. Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015–2020;PLOS Medicine;2023-05-04

5. Nationwide Hepatitis C Serosurvey and Progress Towards Hepatitis C Virus Elimination in the Country of Georgia, 2021;The Journal of Infectious Diseases;2023-03-18